World's Best Scientists 2026 revealed!
Dario Neri

Dario Neri

Award Badge
Medicine
Switzerland
2023

D-Index & Metrics

Immunology

D-Index
111
Citations
39443
World Ranking
485
National Ranking
13

Medicine

D-Index
112
Citations
39807
World Ranking
5194
National Ranking
163

Research.com Recognitions

  • 2023 - Research.com Medicine in Switzerland Leader Award

Overview

Dario Neri is affiliated with ETH Zurich in Switzerland and has an extensive research portfolio primarily situated in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans significant subfields including Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology, and Organic Chemistry.

The scientist has contributed to research on topics such as Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Peptidase Inhibition and Analysis, Chemical Synthesis and Analysis, Immunotherapy and Immune Responses, Radiopharmaceutical Chemistry and Applications, and Immune Cell Function and Interaction.

Several recent papers reflect the scope and diversity of their research interests:

  • DNA-Encoded Chemical Libraries: A Comprehensive Review with Succesful Stories and Future Challenges, 2021, ACS Pharmacology & Translational Science
  • An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications, 2021, Proceedings of the National Academy of Sciences
  • Immunocytokines are a promising immunotherapeutic approach against glioblastoma, 2020, Science Translational Medicine
  • Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA, 2021, European Journal of Nuclear Medicine and Molecular Imaging
  • Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells, 2020, Leukemia

The scientist frequently publishes in several venues, including:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neuro-Oncology
  • Molecular Cancer Therapeutics
  • Annals of Oncology

Frequent collaborators in their research include:

  • Samuele Cazzamalli
  • Emanuele Puca
  • Roberto De Luca
  • Nicholas Favalli
  • Ettore Gilardoni

Best Publications

  • Interfering with pH regulation in tumours as a therapeutic strategy

    Dario Neri;Claudiu T. Supuran

  • Stereospecific nuclear magnetic resonance assignments of the methyl groups of valine and leucine in the DNA-binding domain of the 434 repressor by biosynthetically directed fractional 13C labeling.

    Dario Neri;Thomas Szyperski;Gottfried Otting;Hans Senn

  • Tumour vascular targeting

    Dario Neri;Roy Bicknell

  • Design and Use of a Phage Display Library: HUMAN ANTIBODIES WITH SUBNANOMOLAR AFFINITY AGAINST A MARKER OF ANGIOGENESIS ELUTED FROM A TWO-DIMENSIONAL GEL *

    Alessandro Pini;Francesca Viti;Annalisa Santucci;Barbara Carnemolla

  • Encoded self-assembling chemical libraries

    Samu Melkko;Jörg Scheuermann;Christoph E Dumelin;Dario Neri

  • Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin.

    Laura Borsi;Enrica Balza;Marco Bestagno;Patrizia Castellani

  • DNA-Encoded Chemical Libraries: A Selection System Based on Endowing Organic Compounds with Amplifiable Information.

    Dario Neri;Richard A. Lerner

  • Immunoscintigraphic Detection of the ED-B Domain of Fibronectin, a Marker of Angiogenesis, in Patients with Cancer

    Monica Santimaria;Giovanni Moscatelli;Giuseppe L. Viale;Leonardo Giovannoni

  • Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform.

    Dario Neri;Barbara Carnemolla;Ahuva Nissim;Alessandra Leprini

  • Fibronectin as target for tumor therapy.

    Manuela Kaspar;Luciano Zardi;Dario Neri

  • Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix

    Barbara Carnemolla;Laura Borsi;Enrica Balza;Patrizia Castellani

  • A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo.

    Alessandra Villa;Eveline Trachsel;Manuela Kaspar;Christoph Schliemann

  • Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.

    C. Halin;S. Rondini;F. Nilsson;A. Berndt

  • A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors.

    Nikolaus Krall;Francesca Pretto;Willy Decurtins;Gonçalo J. L. Bernardes;Gonçalo J. L. Bernardes;Gonçalo J. L. Bernardes

  • Selective targeted delivery of TNFα to tumor blood vessels

    Laura Borsi;Enrica Balza;Barbara Carnemolla;Francesca Sassi

  • Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis.

    Francesca Viti;Lorenzo Tarli;Leonardo Giovannoni;Luciano Zardi

  • The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases

    Jascha N. Rybak;Christoph Roesli;Manuela Kaspar;Alessandra Villa

  • Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice.

    Fredrik Nilsson;Hartwig Kosmehl;Luciano Zardi;Dario Neri

  • Antibody-drug conjugates: basic concepts, examples and future perspectives.

    Giulio Casi;Dario Neri

  • Recent advances in osteosarcoma.

    Sander M Botter;Dario Neri;Bruno Fuchs

  • Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C.

    Simon S. Brack;Michela Silacci;Manfred Birchler;Dario Neri

Frequent Co-Authors

Luciano Zardi
Luciano Zardi ETH Zurich
Greg Winter
Greg Winter University of Cambridge
Giovanni Neri
Giovanni Neri Catholic University of the Sacred Heart
Gonçalo J. L. Bernardes
Gonçalo J. L. Bernardes University of Cambridge
Kurt Wüthrich
Kurt Wüthrich ETH Zurich
Michael Detmar
Michael Detmar ETH Zurich
Raffaella Giavazzi
Raffaella Giavazzi Mario Negri Institute for Pharmacological Research
Markus G. Manz
Markus G. Manz University of Zurich
Claus Garbe
Claus Garbe University of Tübingen
Christian Jung
Christian Jung Kiel University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, related healthcare degrees offer valuable pathways to complement and enhance your expertise. Nursing is a common and practical choice, with many students exploring the best online RN programs for non nurses. These programs allow individuals without a nursing background to transition smoothly into the field, opening doors to patient care roles that rely heavily on immunological knowledge.

Accelerated nursing programs also serve as an excellent option for those looking to fast-track their nursing career. The easiest ABSN to get into can make this advanced degree more accessible and affordable, allowing you to quickly gain clinical and theoretical skills that link closely with immunology practices.

For those seeking entry-level positions, programs like the LPN schools easy to get into offer straightforward paths into licensed practical nursing. This foundational role can provide hands-on experience with patient immune responses, an asset in immunology-related fields.

Advancing your career further is possible with specialized programs such as the easiest online nurse practitioner programs. These programs equip nurses with advanced clinical expertise, including immunological assessments, expanding both career opportunities and contributions to healthcare research and practice.

Best Scientists Citing Dario Neri

Trending Scientists

Recently Published Articles